The expression of lncRNA H19 was found to be higher in patients with atherosclerosis, and it promotes atherosclerosis by regulating mitogen-activated protein kinase (MAPK) and nuclear factor (NF)-κ B signaling pathways (Pan, 2017). The gene discussed is WNK2; the disease is atherosclerosis.